Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Bit Digital, Inc. (BTBT) Declines More Than Market: Some Information for Investors
Bit Digital, Inc. (BTBT) Declines More Than Market: Some Information for Investors

Bit Digital, Inc. (BTBT) closed the most recent trading day at $1.72, moving -7.53% from the previous trading session. This move lagged the S&P 500's daily loss of 0.57%. Elsewhere, the Dow lost

Meta Platforms (META) Falls More Steeply Than Broader Market: What Investors Need to Know
Meta Platforms (META) Falls More Steeply Than Broader Market: What Investors Need to Know

Meta Platforms (META) closed at $660.41 in the latest trading session, marking a -1.1% move from the prior day. The stock's change was less than the S&P 500's daily loss of 0.57%. Meanwhile, the Dow

BJ's Wholesale Is Growing, Buying Back Stock, and Still Dirt Cheap
BJ's Wholesale Is Growing, Buying Back Stock, and Still Dirt Cheap

BJ’s Wholesale Club (NYSE: BJ) is a quality buy in 2026 because it is growing, outperforming guidance, has a healthy balance sheet, and offers value relative to competitors.

While it trades in

Gevo, Inc. (GEVO) Reports Q4 Loss, Tops Revenue Estimates
Gevo, Inc. (GEVO) Reports Q4 Loss, Tops Revenue Estimates

Gevo, Inc. (GEVO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.09 per share a year ago. These figures are

Lineage Cell (LCTX) Reports Break-Even Earnings for Q4
Lineage Cell (LCTX) Reports Break-Even Earnings for Q4

Lineage Cell (LCTX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.01 per share a year ago. These figures are

Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates
Metagenomi Therapeutics (MGX) Reports Q4 Loss, Misses Revenue Estimates

Metagenomi Therapeutics (MGX) came out with a quarterly loss of $0.6 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to a loss of $0.63 per share a year ago. These

Samsara Inc. (IOT) Q4 Earnings and Revenues Beat Estimates
Samsara Inc. (IOT) Q4 Earnings and Revenues Beat Estimates

Samsara Inc. (IOT) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.11 per share a year ago. These

Traeger (COOK) Q4 Earnings Miss Estimates
Traeger (COOK) Q4 Earnings Miss Estimates

Traeger (COOK) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago. These figures

Costco (COST) Q2 Earnings and Revenues Top Estimates
Costco (COST) Q2 Earnings and Revenues Top Estimates

Costco (COST) came out with quarterly earnings of $4.58 per share, beating the Zacks Consensus Estimate of $4.55 per share. This compares to earnings of $4.02 per share a year ago. These figures are

The Cooper Companies (COO) Q1 Earnings Surpass Estimates
The Cooper Companies (COO) Q1 Earnings Surpass Estimates

The Cooper Companies (COO) came out with quarterly earnings of $1.1 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.92 per share a year ago. These

OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates

OptimizeRx Corp. (OPRX) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.3 per share a year ago. These

Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates

Profound Medical (PROF) came out with a quarterly loss of $0.27 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.2 per share a year ago. These figures are adjusted

GoPro (GPRO) Reports Q4 Loss, Lags Revenue Estimates
GoPro (GPRO) Reports Q4 Loss, Lags Revenue Estimates

GoPro (GPRO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.04. This compares to a loss of $0.09 per share a year ago. These figures are adjusted for

Marvell Technology (MRVL) Q4 Earnings and Revenues Top Estimates
Marvell Technology (MRVL) Q4 Earnings and Revenues Top Estimates

Marvell Technology (MRVL) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.6 per share a year ago. These

Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates

Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.39 per share a year ago

AudioEye (AEYE) Tops Q4 Earnings and Revenue Estimates
AudioEye (AEYE) Tops Q4 Earnings and Revenue Estimates

AudioEye (AEYE) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.18 per share a year ago. These figures

Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca

Thursday, March 5, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil

Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape
Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

After pulling back sharply from its 52-week high, Rocket Lab (NASDAQ: RKLB) appears to be carving out a meaningful support zone.

Shares are down nearly 30% from their record highs, pressured by

Insiders Are Buying These 3 Energy Stocks
Insiders Are Buying These 3 Energy Stocks

Many investors keep a close eye on insider transactions, as they can often give a decent read surrounding the longer-term picture.

Of course, it’s important to note that insiders have a longer

Cash Flow Kings: 2 Stocks to Hide In, 1 to Avoid
Cash Flow Kings: 2 Stocks to Hide In, 1 to Avoid

In today’s markets, where macroeconomic concerns, fears centered on AI spending and disruption, inflation, and interest rates weigh on performance, cash flow is king. Companies that produce

Do Options Traders Know Something About Crane NXT Stock We Don't?
Do Options Traders Know Something About Crane NXT Stock We Don't?

Investors in Crane NXT, Co. CXT need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $65 Call had some of the highest implied

Implied Volatility Surging for Quest Diagnostics Stock Options
Implied Volatility Surging for Quest Diagnostics Stock Options

Investors in Quest Diagnostics Incorporated DGX need to pay close attention to the stock based on moves in the options market lately. That is because the March 20, 2026 $130 Call had some of the

Ross Stores Proves the Off-Price Uptrend Is Far From Over
Ross Stores Proves the Off-Price Uptrend Is Far From Over

Ross Stores’ (NASDAQ: ROST) stock price is in an uptrend, and its Q4 2025 earnings release proves that it isn’t over. Including top- and bottom-line outperformance, compounded by robust

Why the Integrity Viking Funds Deal Is a Win for Fidelity National
Why the Integrity Viking Funds Deal Is a Win for Fidelity National

Fidelity National Information Services, Inc. FIS scored a new business win as Integrity Viking Funds chose the FIS Investment Accounting Manager platform to modernize its investment accounting

Norwegian Hit Rough Seas After Earnings—Viking Cruised Through
Norwegian Hit Rough Seas After Earnings—Viking Cruised Through

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) and Viking Holdings Ltd. (NYSE: VIK) reported earnings on March 2 and March 3, respectively.

Heading into earnings, analysts were more bullish